Custom cancer treatment.
Human cells need to produce the correct proteins at the right time and in the appropriate quantities to stay healthy. One of the key means by which cells achieve this control is by "RNA interference," a form of gene silencing where small pieces of RNA, called micro RNAs, obstruct the production of specific proteins by interacting with their genetic code. However, not any piece of RNA can do this. The researchers used structural biology to unravel how a small segment in the Argonaute proteins, the key molecules of RNA interference, can select the correct micro RNAs.
In doing so, the team has discovered that Argonaute proteins can potentially be exploited to enhance gene silencing. "RNA interference could be used as a viable therapeutic approach for inhibiting specific genes that are aberrantly active in diseases such as cancer," lead researcher Bhushan Nagar said. "We now have a handle on being able to rationally modify micro RNAs to make them more efficient and possibly into therapeutic drugs."
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||CHEMICAL NEWS/ACTUALITE CHIMIQUE|
|Publication:||Canadian Chemical News|
|Date:||Jun 1, 2010|
|Previous Article:||Let them eat eggs.|
|Next Article:||Two benefits, one switch.|